MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress » Rating Scales

Date: Monday, October 8, 2018

Time: 1:15pm-2:45pm

Location: Hall 3FG

Meeting: 2018 International Congress

1:15pm-2:45pm
A Psychometric Analysis of the MDS UPDRS-II and III in Early Parkinson’s disease: Do the Numbers Add Up?

A. Regnault, B. Boroodjerdi, J. Meunier, M. Bani, S. Cano (Lyon, France)

1:15pm-2:45pm
Applying Intervention Mapping methodologies to enhance Data Completeness in Movement Disorders-related Scales

C. Goetz, S. Luo, G. Stebbins (Chicago, IL, USA)

1:15pm-2:45pm
Are the MDS-UPDRS-based composite scores clinically applicable?

N. Kovács, A. Juhász, Z. Aschermann (Pécs, Hungary)

1:15pm-2:45pm
Assessing hemifacial spasm: The HFSG scale

S. Simoni, N. Tambasco, E. Sacchini, E. Marsili, P. Nigro, E. Brahimi, M. Romoli, F. Paolini Paoletti, M. Filidei, P. Calabresi (Perugia, Italy)

1:15pm-2:45pm
Assessing the Quality of Economic Evaluation of Treatment Options for Parkinson’s disease Using the Quality of Health Economic Studies (QHES) Scale

M. Azharuddin, M. Adil, P. Ghosh, M. Sharma (New Delhi, India)

1:15pm-2:45pm
Differences in the Unified Dyskinesia Rating Scale based on age, Parkinson´s Disease and Dyskinesias duration

E. Cubo, S. Luo, S. Calvo, P. Martinez-Martín (Burgos, Spain)

1:15pm-2:45pm
Functional Balance and Neuromuscular Strength Difficulties Like Fracture Predictors in a Parkinsonian Population

L. Leandro, C. Moreira, H. Teive (Curitiba, Brazil)

1:15pm-2:45pm
FuRST2.0: Development of a modified functional rating scale for use in premanifest and early-manifest Huntington’s disease

R. Fuller, P. Feigenbaum, C. Fitzer-Attas, N. La Pelle, S. Luo, C. Sampaio, G. Stebbins (Princeton, NJ, USA)

1:15pm-2:45pm
Impact of postural stability estimation in HY scale. (Pull test Vs. limits of stability assessment)

P. Serrano, A. Arroyo, J. Andreo, V. Cortés, JP. Romero (Madrid, Spain)

1:15pm-2:45pm
Item Response Theory Analysis of the Unified Dyskinesia Rating Scale Items

C. Goetz, S. Luo, G. Stebbins (Chicago, IL, USA)

1:15pm-2:45pm
Missing Data in the Unified Dyskinesia Rating Scale (UDysRS)

S. Luo, X. Ren, W. Han, C. Goetz, G. Stebbins (Durham, NC, USA)

1:15pm-2:45pm
Naturalistic-based UPDRS-III Minimal Clinically Important Difference (MCID) in early PD

M. Matarazzo, P. Martínez Martín, J.C. Martínez-Ávila, A. Gómez de-la-Cámara, L. Giancardo, T. Arroyo Gallego, P. Montero Escribano, V. Puertas-Martín, I. Obeso, I. Butterworth, C.S. Mendoza, M.J. Catalán, J.A. Molina-Arjona, F. Bermejo-Pareja, J.C. Martínez-Castrillo, L. López-Manzanares, A. Alonso-Canovas, J. Herreros-Rodríguez, M. Gray, Á. Sánchez-Ferro (Vancouver, BC, Canada)

1:15pm-2:45pm
Pilot study of a new tool to optimize dopaminergic treatment in Parkinson’s disease: The OPTIPARK Scale Project

J. Máñez Miró, F. Vivancos-Matellano, P. Martínez-Martín (Mostoles, Spain)

1:15pm-2:45pm
Preliminary Results of Psychometric Properties of the Freezing of Gait Questionnaire in Turkish Patients with Parkinson’s Disease

E A. Ozturk, F. Nazli, B. Gonenli Kocer, S B. Tonuk, A. Can, N. Tezel, C. Uz, O. Ecerkale, F A. Cakci (Ankara, Turkey)

1:15pm-2:45pm
Preliminary Results of Psychometric Properties of the Turkish version of Falls Efficacy Scale – International in Patients with Parkinson’s Disease

F. Nazli, E A. Ozturk, B. Gonenli Kocer, S B. Tonuk, N. Tezel, A. Can, C. Uz, O. Ecerkale, F A. Cakci (Ankara, Turkey)

1:15pm-2:45pm
Prevalence of Patient-Reported Symptoms of Dysphonia and Dysphagia in Movement Disorder Patients at an Academic Medical Center

M. Finger, M. Siddiqui, J. Tate, I. Haq, L. Madden (Winston-Salem, NC, USA)

1:15pm-2:45pm
Rasch analysis of the Hospital Anxiety and Depression Scale among patients with early-stage Parkinson’s disease

H.J. Yang, B.S. Park, J.Y. Park, E.M. Lee, S.Y. Kim, W.J. Kim, J.H. Kwon (Ulsan, Republic of Korea)

1:15pm-2:45pm
The Inter-rater Reliability of Parkinson’s Disease Sleep Scale 2 Indonesian Version

R. Buana, R. Pinzon (Yogyakarta, Indonesia)

1:15pm-2:45pm
The International Parkinson and Movement Disorder Society Non-Motor Scale (MDS-NMS) for Parkinson’s Disease: Preliminary results from an international validation

K. Ray Chaudhuri, D. Weintraub, A. Rizos, A. Schrag, P. Martinez-Martin (London, United Kingdom)

1:15pm-2:45pm
The Reliability Study of King’s Parkinson’s Disease Pain Scale in Indonesian Version

V. Wijaya, R. Pinzon (Yogyakarta, Indonesia)

1:15pm-2:45pm
Usefulness of a simple symptom assessment scale for multiple system atrophy: data from HoRC-MSA Project

M. Matsushima, K. Sakushima, I. Yabe, Y. Kanatani, Y. Ito, T. Matsuoka, T. Katayama, H. Uesugi, K. Sako, A. Takei, S. Shimohama, N. Sato, S. Kikuchi, H. Sasaki (Sapporo, Japan)

1:15pm-2:45pm
Validation of the Parkinson’s Disease Pain Symptoms Scale (PD-PSS): An interim report

D. Ciampi-de-Andrade, S. Perez-Lloret, N. Hollenstein, R. Curry, V. Rossetto Barbosa, G. Kägi, S. Hägele-Link, J. Walch, R. Gonzenbach, J-P. Lefaucheur, S. Beer, C. Möller, V. Mylius (Sao Paulo, Brazil)

1:15pm-2:45pm
Validity And Reliability Of Nineteen-Item Wearing-Off Questionnaire In Turkish Patients

H. Çotur Levent, AY. Yılmaz, MC. Akbostancı (Ankara, Turkey)

« View all sessions from the 2018 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley